Well-known pharmacy industry leader Joins CrossBridge as VP, Pharmacoeconomics & Outcomes - CrossBridge
15617
post-template-default,single,single-post,postid-15617,single-format-standard,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Well-known pharmacy industry leader Joins CrossBridge as VP, Pharmacoeconomics & Outcomes

Well-known pharmacy industry leader Joins CrossBridge as VP, Pharmacoeconomics & Outcomes

Wayne, PA, October 21, 2019 – Paul Polansky, a veteran healthcare  consultant specializing in Pharmacoeconomics, has joined Wayne, Pennsylvania-based CrossBridge, LLC as Vice President Pharmacoeconomics & Outcomes.

In welcoming Pollansky to CrossBridge, Bill Conlan, the CrossBridge CEO had this to say:  “Considering our mission of controlling costs and improving outcomes in complex, chronic diseases, Paul’s expertise will be critical to our business.  The treatment of these diseases often includes expensive pharmacologic solutions that must be correctly prescribed.”

Polansky comes to CrossBridge from his consultancy, PAPRx, through which he has provided consulting and management services to Specialty Pharmacy, PBMs, payers and providers.

He co-founded and served as EVP, Chief Pharmacy Officer at Sanovia, a company that markets specialty drug pre-authorization software to PBMs and payers.  He has also served as Senior Liaison, Health Economics and Outcome Research for Endo Health Solutions and Scientific Specialist, Health Outcomes and Pharmacoenomics for UCB, Inc.

About CrossBridge

CrossBridge is an early-stage healthcare technology company, specializing in Software as a Service (SaaS) solutions that enable payers and healthcare providers to strive collaboratively for the best outcomes at the lowest cost for chronic diseases – all while advancing the transition from fee-for-service to Value Based Payments (VBP).

No Comments

Post A Comment